RxSight, Inc. to Present at the Bank of America Healthcare Conference
RxSight, a medical device company focused on ophthalmic solutions, will present at the Bank of America Healthcare Conference on May 10, 2022, at 12:00 PM PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight, a medical device company focused on ophthalmic solutions, will present at the Bank of America Healthcare Conference on May 10, 2022, at 12:00 PM PT. This event will showcase the company's innovative RxSight Light Adjustable Lens system, which allows for customized visual acuity post-cataract surgery. The system now includes ActivShield technology for added UV protection. A live and archived webcast of the presentation will be available on their website under the 'Investors' section.
Details
News Market Reaction – RXST
The recorded move for RXST in the trading session of this news was -8.32%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference.
RxSight’s management is scheduled to present Tuesday, May 10, 2022, at 12:00pm PT / 3:00pm ET. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
IR@rxsight.com
Company Contact:
Shelley Thunen
RxSight, Inc.
949-521-7830
IR@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.